Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Orencia (Abatacept) Antibody (310G6.01), Biotin, Novus Biologicals™
SDP

Catalog No. DDX5041B100 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
DDX5041B100 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. DDX5041B100 Supplier Novus Biologicals Supplier No. DDX5041B100
Only null left
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Orencia (Abatacept) Monoclonal specifically detects Orencia (Abatacept) in Human samples. It is validated for ELISA.

Specifications

Antigen Orencia (Abatacept)
Applications ELISA
Classification Monoclonal
Clone 310G6.01
Concentration 50 mg/mL
Conjugate Biotin
Dilution ELISA
Formulation PBS 50%, glycerol with No Preservative
Gene Alias 332348-12-6, ABATACEPT (GENETICAL RECOMBINATION), BMS-188667, CTLA4-IGG4M, Fusion protein with an extracellular domain of human cytotoxic T-lymphocyte-associated antigen (CTLA-4) and modified Fc domain of human immunoglobulin G1, RG-1046
Host Species Mouse
Immunogen Orencia (Abatacept)
Purification Method Ion exchange chromatography
Quantity 0.1 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Form Purified
Isotype IgG1
Show More Show Less

For Research Use Only (RUO)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.